A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)
Type 2 Diabetes, Obesity, Overweight
About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria: Have a body mass index (BMI) greater than or equal to 27.0 kilogram/square meter (kg/m ²) Have Type 2 Diabetes (T2D) Are on stable treatment for T2D for at least 90 days Have a history of at least one unsuccessful dietary effort to lose body weight. GSA2 Inclusion Criteria Previously diagnosed with OSA Have AHI ≥15 on polysomnography at screening (definition of moderate-to-severe OSA) For participants not on positive airway pressure (PAP) therapy: unable or unwilling to use PAP therapy and have not used PAP for at least 4 weeks prior to screening. If on PAP therapy, have been on PAP therapy for at least 3 consecutive months prior to screening, and willing to temporarily stop using PAP therapy for approximately 7 days prior to each of the sleep study (PSG) visits. Exclusion Criteria: Have a self-reported or documented change in body weight >5 kg (11 pounds) within 90 days. Have taken weight loss drugs, including over-the-counter medications, within 90 days prior to screening. Have a prior or planned surgical treatment for obesity. Have Type 1 diabetes Have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2) Have had pancreatitis GSA2 Exclusion Criteria Use stimulants (for example, modafinil, armodafinil, solriamfetol, pitolisant, amphetamine) less than 3 months prior to screening. Use hypnotics, mirtazapine, opioids, trazodone, and zonisamide less than 3 months prior to screening. Use a dental appliance or other device to treat OSA other than PAP therapy.
Sites / Locations
- National Research Institute - WilshireRecruiting
- Valley Clinical Trials, Inc.Recruiting
- Diablo Clinical Research, Inc.Recruiting
- Chase Medical Research, LLCRecruiting
- Teradan Clinical Trials, LLCRecruiting
- Renstar Medical ResearchRecruiting
- Palm Beach Research CenterRecruiting
- NeuroTrials Research IncRecruiting
- East-West Medical Research InstituteRecruiting
- Brengle Family MedicineRecruiting
- MedVadis Research CorporationRecruiting
- StudyMetrix ResearchRecruiting
- Las Vegas Medical ResearchRecruiting
- Carteret Medical GroupRecruiting
- Lillestol ResearchRecruiting
- CTI-CRCRecruiting
- Office 18Recruiting
- Tribe Clinical Research, LLCRecruiting
- Trial Management AssociatesRecruiting
- Tribe Clinical Research - SpartanburgRecruiting
- FutureSearch Trials of NeurologyRecruiting
- Dallas Diabetes Research CenterRecruiting
- Advanced Research InstituteRecruiting
- Centro Médico Viamonte
- Consultorio de Investigación Clínica EMO SRL
- Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
- Centro de Salud e Investigaciones Médicas
- The AIM Centre / Hunter Diabetes CentreRecruiting
- Woolcock Institute of Medical ResearchRecruiting
- Royal Brisbane and Women's HospitalRecruiting
- Core Research GroupRecruiting
- Nightingale ResearchRecruiting
- Southern Adelaide Diabetes & Endocrine ServicesRecruiting
- Flinders UniversityRecruiting
- Box Hill HospitalRecruiting
- Austin Health - Repatriation HospitalRecruiting
- GenesisCareRecruiting
- The Second Affiliated Hospital of Zhengzhou University
- Baotou Central Hospital
- Nanjing First Hospital
- The Second Affiliated Hospital of Nanjing Medical University
- The First Hospital of Jilin University
- The First Affiliated Hospital of Xi'an Medical University
- Pudong New Area People's Hospital Shanghai
- West China Hospital of Sichuan University
- Ningbo First Hospital
- V.S. General Hospital
- Avron Hospitals
- Zydus Hospitals & Healthcare Research Pvt.Ltd.
- Life Care Hospital and Research CentreRecruiting
- Sushruta Multispeciality Hospital & Research Centre
- CHL Hospital IndoreRecruiting
- Sawai Man Singh Medical College Hospital (SMS Hospital)
- Madras Diabetes Research Foundation
- Christian Medical College Vellore
- Care Hospitals Hyderabad- Banjara HillsRecruiting
- Kumudini Devi Diabetes Research Center
- Institute of Post Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital
- Korea University Ansan HospitalRecruiting
- Hanyang University Guri HospitalRecruiting
- Yeungnam Univeristy Medical CenterRecruiting
- Seoul National University HospitalRecruiting
- Severance Hospital, Yonsei University Health System
- Ulsan University Hospital
- Centro de Investigacion en Artritis y Osteoporosis SC
- RM Pharma Specialists
- Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
- Diseno y Planeacion en Investigacion Medica
- Private Practice - Dr. Arechavaleta Granell Maria del Rosario
- Unidad de Investigación Clínica y Atención Médica HEPA
- Cardiolink Clin Trials
- Investigacion En Salud Y Metabolismo S.C / Nutricion Clinica / Unidad de Base de Datos
- FAICIC S. de R.L. de C.V.
- Arké SMO S.A de C.V
- DiabdanaRecruiting
- Geea Medical Easy DietRecruiting
- Centrul Medical NutriLifeRecruiting
- Gama DiamedRecruiting
- Centrul Medical MediabRecruiting
- CMI Dr.Pletea Noemi SRLRecruiting
- Centro Periférico de Especialidades Bola AzulRecruiting
- Hospital Universitario Virgen de la VictoriaRecruiting
- Complejo Asistencial Universitario de León - Hospital de LeónRecruiting
- Hospital Universitario Ramón y CajalRecruiting
- Vithas Hospital SevillaRecruiting
- Hospital Universitario Virgen Del RocioRecruiting
- Chang Gung Memorial Hospital at Kaohsiung
- Chung Shan Medical University Hospital
- Taipei Veterans General Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
Retatrutide Dose 1
Retatrutide Dose 2
Retatrutide Dose 3
Placebo
Participants will receive retatrutide subcutaneously (SC).
Participants will receive retatrutide SC.
Participants will receive retatrutide SC.
Participants will receive placebo.